STOCK TITAN

Osmotica to Present at Barclays Global Healthcare Conference 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Osmotica Pharmaceuticals (Nasdaq: OSMT) announced that CEO Brian Markison and CFO Andrew Einhorn will present at the Barclays Global Healthcare Conference on March 9, 2021, at 9:45 a.m. Eastern Time. The presentation will be available via webcast at this link. Osmotica focuses on developing specialty biopharmaceuticals, with operations in the U.S., Argentina, and Hungary, and offers a diverse portfolio, including products from its ophthalmic subsidiary, RVL Pharmaceuticals.

Positive
  • None.
Negative
  • None.

BRIDGEWATER, N.J., March 03, 2021 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, announced today that Brian Markison, Chief Executive Officer, and Andrew Einhorn, Chief Financial Officer, will present at the Barclays Global Healthcare Conference 2021 as follows:

Date:Tuesday, March 9, 2021
Time:9:45 a.m. Eastern Time
Webcast:https://kvgo.com/2021-global-healthcare-conference/osmotica-march-2021
  

About Osmotica Pharmaceuticals plc

Osmotica Pharmaceuticals plc (Nasdaq: OSMT) is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations. The company has a diverse portfolio consisting of promoted and non-promoted products, several of which incorporate Osmotica’s proprietary Osmodex® drug delivery system. RVL Pharmaceuticals, Inc. is the Company’s ophthalmic subsidiary supporting Upneeq®. Vertical Pharmaceuticals, LLC represents the Company’s diversified branded portfolio and Trigen Laboratories, LLC represents the Company’s non-promoted products, including complex generic formulations. Osmotica has operations in the United States, Argentina, and Hungary.

Investor and Media Relations for Osmotica Pharmaceuticals plc
Lisa M. Wilson
In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com


FAQ

When is Osmotica Pharmaceuticals presenting at the Barclays Global Healthcare Conference 2021?

Osmotica Pharmaceuticals will present on March 9, 2021, at 9:45 a.m. Eastern Time.

Who will represent Osmotica Pharmaceuticals at the Barclays Global Healthcare Conference?

CEO Brian Markison and CFO Andrew Einhorn will represent Osmotica Pharmaceuticals.

How can I watch the Osmotica Pharmaceuticals presentation at the Barclays Global Healthcare Conference?

The presentation can be watched via webcast at the following link: https://kvgo.com/2021-global-healthcare-conference/osmotica-march-2021.

What is the focus of Osmotica Pharmaceuticals?

Osmotica Pharmaceuticals focuses on developing specialty biopharmaceutical products for underserved patient populations.

Where does Osmotica Pharmaceuticals operate?

Osmotica Pharmaceuticals operates in the United States, Argentina, and Hungary.

OSMT

NASDAQ:OSMT

OSMT Rankings

OSMT Latest News

OSMT Stock Data

32.31M
0.28%
Medicinal and Botanical Manufacturing
Manufacturing
Link
US
Bridgewater